Friday, November 22, 2024
HomeTagsKineta

Kineta

Kineta Presents New Preclinical Data and Phase 1/2 Clinical Trial Design of KVA12.1 at the Tumor Myeloid-Directed Therapies Summit

Kineta, Inc. ("Kineta" or the "Company"), a clinical-stage biotechnology company focused on the development of novel immunotherapies in oncology, announced that it presented the...

Kineta Unveils New Preclinical Data on its Anti-CD27 Agonist Lead Antibodies at AACR 2022

Kineta, Inc., a clinical stage biotechnology company focused on the development of novel immunotherapies in oncology, announced the presentation of preclinical data on the...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics